Enoxacin treatment of urinary tract infections.
We treated 20 patients with urinary tract infections with enoxacin, a new nalidixic acid analogue, in an open uncontrolled trial. Twelve of 13 patients with covert bacteriuria or cystitis and four of seven patients with pyelonephritis were cured. Two treatment failures occurred in patients with complicated infections. Nine patients reported mild side-effects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D015365:Enoxacin; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009287:Naphthyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D009287:Naphthyridines; D015365:Enoxacin